Sleep and Cognition After Ambulatory Hip and Knee Arthroplasty

February 16, 2020 updated by: Alexandre Garioud, Hvidovre University Hospital

Sleep and rest are key elements in postoperative rehabilitation and recovery. There are complex relations between major surgery, sleep disturbance and complications. Major surgery leeds to severe postoperative sleep disturbances, initially reducing REM sleep time and disturbing the remaining sleep stages. Major surgery is again a risk factor for postoperative delirium and other cognitive impairment. The underlying mechanisms includes pain, opioid medication, sleep disturbances and neuroinflammation, along with external factors as noise during hospitalisation. The physiologic stress from sleep disturbances and sleep deprivation is associated with blood-brain barrier impairment, inflammation, decreased restitution, altered nociceptive function. Likewise, undiagnosed and untreated sleep apnea is a risk for postoperative complications and is itself affected by anesthesia and some analgesics (i.a. opioids).

Fast-track surgery development has led to restitution period shortening, optimized pain management reducing opioid use, postoperative inflammatory stress response reduction and less delirium. Evolution of hip and knee arthroplasty(THA/TKA), organisation, optimized pain management and pharmacologic modification of inflammatory response by high dose steroid has permitted to perform these surgeries in an outpatient setting.

Previous studies of fast-track THA/TKA using multimodal opioid-sparring analgesia, however neither using high dose steroids nor in an out patient setting, have demonstrated REM sleep period reduction from a normal range of 18% preoperatively to 1% postoperatively. However, changes in sleep architecture after THA/TKA in at setting attempting to minimise abnormal sleep by means of ambulatory surgery added to perioperative reduction of inflammatory response to surgery, pain and opioid use by high dose steroid, haven't been studied.

The purpose of this study is to investigate how much an optimized ambulatory THA/TKA , reducing pain and inflammatory response to surgery and opioid use by high doses steroid can conserve the preoperative sleep architecture.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

16

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

16 adult attending scheduled hip or knee arthroplasty in an ambulatory fast-track setting with spinal anesthesia corresponding to the above mentioned inclusion criteria.

Description

Inclusion Criteria:

  • ASA classification I or II
  • Scheduled hospital discharge same day after surgery
  • Adult person following the patient 24 hours at the patients habitation
  • Informed consent and signature.
  • Patient speaks and understands Danish

Exclusion Criteria:

  • Hospital discharge later than same day after surgery
  • No consent form patient
  • Alcohol or drug abuse
  • Anxiolytic og antipsychotic treatment
  • Preoperative opioid treatment
  • Soporific treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in postoperative REM sleep time compared to preoperative
Time Frame: One night 2 to 4 night preoperatively, and the first and second postoperative night.
Polysomnography
One night 2 to 4 night preoperatively, and the first and second postoperative night.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes Remaining sleep stages and sleep variables (i.a. apnea)
Time Frame: One night 2 to 4 night preoperatively, and the first and second postoperative night.
Polysomnography
One night 2 to 4 night preoperatively, and the first and second postoperative night.
Presence and severity of postoperative delirium compared to preoperative
Time Frame: One night 2 to 4 night preoperatively, and after the second postoperative night.
Confusion Assessement Method-Severity (CAM-S). High scores, better outcome.
One night 2 to 4 night preoperatively, and after the second postoperative night.
Presence and severity of postoperative cognitive impairment compared to preoperative
Time Frame: One night 2 to 4 night preoperatively, and after the second postoperative night.
Mini Mental State Examination (MMSE), High scores, better outcome.
One night 2 to 4 night preoperatively, and after the second postoperative night.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective measurement of tiredness
Time Frame: One night 2 to 4 night preoperatively, and after the second postoperative night.
questionnaire. Better sleep, better outcome.
One night 2 to 4 night preoperatively, and after the second postoperative night.
Subjective measurement of sleep quality
Time Frame: One night 2 to 4 night preoperatively, and after the second postoperative night.
Pittsburgh Sleep Quality Index. Lower score, better outcome.
One night 2 to 4 night preoperatively, and after the second postoperative night.
Changes in preoperative inflammatory marker level (CRP) compared to postoperative.
Time Frame: One night 2 to 4 night preoperatively, and after the second postoperative night.
Blod samples
One night 2 to 4 night preoperatively, and after the second postoperative night.
Subjective measurements of pain at rest and after mobilisation.
Time Frame: Immediately after surgery, and after the first and second postoperative night.
questionnaire. Visual Analogue Scale(VAS). Lower score, better outcome.
Immediately after surgery, and after the first and second postoperative night.
Registration of opioid use.
Time Frame: Immediately after surgery, and after the first and second postoperative night.
questionnaire. Less opioid use, better outcome.
Immediately after surgery, and after the first and second postoperative night.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Henrik Kehlet, Dr.med,Phd, Rigshospitalet, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2020

Primary Completion (Anticipated)

July 1, 2020

Study Completion (Anticipated)

July 1, 2020

Study Registration Dates

First Submitted

December 12, 2019

First Submitted That Met QC Criteria

January 11, 2020

First Posted (Actual)

January 14, 2020

Study Record Updates

Last Update Posted (Actual)

February 18, 2020

Last Update Submitted That Met QC Criteria

February 16, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

3
Subscribe